- 9/12/2011 - Shareholder Update - December edition of BITNews
- 9/12/2011 - Change of Director's Interest Notice
- 8/12/2011 - Change of Director's Interest Notice
- 7/12/2011 - Biotron Announces Positive Three Month Data for BIT225 - 87% Virus Free
- 30/11/2011 - Option Expiry Notice
- 30/11/2011 - Change of Director's Interest Notice
- 25/11/2011 - Issue Shares
- 22/11/2011 - Results of Annual General Meeting
- 22/11/2011 - Presentation to Annual General Meeting
- 18/11/2011 - Dr Michael Hirshorn
- 18/11/2011 - Biotron Selected to Present at International Hepatitis Conference
- 27/10/2011 - Appendix 4C - Quarterly Report 30 September 2011
- 24/10/2011 - Annual Report for year ended 30 June 2011 and Notice of Annual General Meeting
- 24/10/2011 - Issue Shares
- 24/10/2011 - Shareholder Update - October edition of BITNews
- 11/10/2011 - Boardroom Radio Broadcast
- 10/10/2011 - Hepatitis C Phase 2A Trial Positive Results
- 29/09/2011 - Landmark HIV Trial Underway
- 30/08/2011 - Year End Accounts and Preliminary Final Report for year ended 30 June 2011
- 29/07/2011 - Shareholder Update - July edition of BITNews
- 27/07/2011 - Appendix 4C - Quarterly Report 30 June 2011
- 7/07/2011 - Final Patient Dosed in Landmark Hep C Trial
- 1/07/2011 - CEO Presentation at BIO2011 in Washington DC
- 19/04/2011 - Appendix 4C - Quarterly Report 31 March 2011
- 4/04/2011 - New Issue
- 31/03/2011 - Presentation to Investors
- 16/03/2011 - Shareholder Update - March edition of BITNews
- 10/03/2011 - Stage One of Landmark Hepatitis C Drug Trial Completed
- 28/02/2011 - Appendix 4D - Half Year Report 31 December 2010
- 24/02/2011 - Biotron Share Purchase Plan
- 27/01/2011 - Appendix 4C - Quarterly Report 31 December 2010
- 12/01/2011 - US Biotech Showcase Presentation
 |
 |
 |
 |
Latest share price
ASX:BIT
ASX:BIT